Logo image of VHI

VALHI INC (VHI) Stock Fundamental Analysis

NYSE:VHI - New York Stock Exchange, Inc. - US9189052098 - Common Stock - Currency: USD

17.68  -0.06 (-0.34%)

After market: 17.68 0 (0%)

Fundamental Rating

5

Taking everything into account, VHI scores 5 out of 10 in our fundamental rating. VHI was compared to 85 industry peers in the Chemicals industry. VHI has only an average score on both its financial health and profitability. VHI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year VHI was profitable.
VHI had a negative operating cash flow in the past year.
Of the past 5 years VHI 4 years were profitable.
Each year in the past 5 years VHI had a positive operating cash flow.
VHI Yearly Net Income VS EBIT VS OCF VS FCFVHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.25%, VHI is in the better half of the industry, outperforming 74.12% of the companies in the same industry.
With a decent Return On Equity value of 11.02%, VHI is doing good in the industry, outperforming 76.47% of the companies in the same industry.
VHI's Return On Invested Capital of 5.83% is in line compared to the rest of the industry. VHI outperforms 60.00% of its industry peers.
Industry RankSector Rank
ROA 4.25%
ROE 11.02%
ROIC 5.83%
ROA(3y)2.2%
ROA(5y)2.55%
ROE(3y)6.18%
ROE(5y)8.39%
ROIC(3y)N/A
ROIC(5y)N/A
VHI Yearly ROA, ROE, ROICVHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

Looking at the Profit Margin, with a value of 5.54%, VHI is in the better half of the industry, outperforming 69.41% of the companies in the same industry.
In the last couple of years the Profit Margin of VHI has grown nicely.
The Operating Margin of VHI (9.31%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of VHI has grown nicely.
The Gross Margin of VHI (21.90%) is worse than 61.18% of its industry peers.
VHI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.31%
PM (TTM) 5.54%
GM 21.9%
OM growth 3Y-11.53%
OM growth 5Y1.8%
PM growth 3Y-2.52%
PM growth 5Y14.63%
GM growth 3Y-7.09%
GM growth 5Y-2.42%
VHI Yearly Profit, Operating, Gross MarginsVHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VHI is destroying value.
The number of shares outstanding for VHI remains at a similar level compared to 1 year ago.
Compared to 5 years ago, VHI has about the same amount of shares outstanding.
The debt/assets ratio for VHI is higher compared to a year ago.
VHI Yearly Shares OutstandingVHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
VHI Yearly Total Debt VS Total AssetsVHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 1.86 indicates that VHI is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of VHI (1.86) is comparable to the rest of the industry.
VHI has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
VHI has a Debt to Equity ratio of 0.49. This is in the better half of the industry: VHI outperforms 67.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z 1.86
ROIC/WACC0.67
WACC8.66%
VHI Yearly LT Debt VS Equity VS FCFVHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

VHI has a Current Ratio of 2.67. This indicates that VHI is financially healthy and has no problem in meeting its short term obligations.
VHI has a better Current ratio (2.67) than 76.47% of its industry peers.
A Quick Ratio of 1.29 indicates that VHI should not have too much problems paying its short term obligations.
VHI has a Quick ratio (1.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 1.29
VHI Yearly Current Assets VS Current LiabilitesVHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 888.46% over the past year.
The Earnings Per Share has been growing by 14.04% on average over the past years. This is quite good.
VHI shows a small growth in Revenue. In the last year, the Revenue has grown by 7.82%.
The Revenue has been growing slightly by 2.10% on average over the past years.
EPS 1Y (TTM)888.46%
EPS 3Y-5.31%
EPS 5Y14.04%
EPS Q2Q%318.52%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y-2.86%
Revenue growth 5Y2.1%
Sales Q2Q%1.51%

3.2 Future

Based on estimates for the next years, VHI will show a small growth in Earnings Per Share. The EPS will grow by 6.52% on average per year.
VHI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.77% yearly.
EPS Next Y0.91%
EPS Next 2Y6.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.92%
Revenue Next 2Y9.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VHI Yearly Revenue VS EstimatesVHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
VHI Yearly EPS VS EstimatesVHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.31 indicates a rather cheap valuation of VHI.
VHI's Price/Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 97.65% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.50. VHI is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 4.81, the valuation of VHI can be described as very cheap.
98.82% of the companies in the same industry are more expensive than VHI, based on the Price/Forward Earnings ratio.
VHI is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.31
Fwd PE 4.81
VHI Price Earnings VS Forward Price EarningsVHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 96.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.42
VHI Per share dataVHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VHI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.76
PEG (5Y)0.31
EPS Next 2Y6.52%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.73%, VHI has a reasonable but not impressive dividend return.
VHI's Dividend Yield is comparable with the industry average which is at 3.53.
VHI's Dividend Yield is slightly below the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.73%

5.2 History

The dividend of VHI decreases each year by -19.61%.
VHI has paid a dividend for at least 10 years, which is a reliable track record.
VHI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-19.61%
Div Incr Years0
Div Non Decr Years3
VHI Yearly Dividends per shareVHI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

7.77% of the earnings are spent on dividend by VHI. This is a low number and sustainable payout ratio.
DP7.77%
EPS Next 2Y6.52%
EPS Next 3YN/A
VHI Yearly Income VS Free CF VS DividendVHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
VHI Dividend Payout.VHI Dividend Payout, showing the Payout Ratio.VHI Dividend Payout.PayoutRetained Earnings

VALHI INC

NYSE:VHI (7/18/2025, 8:04:00 PM)

After market: 17.68 0 (0%)

17.68

-0.06 (-0.34%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-31 2025-07-31
Inst Owners4.97%
Inst Owner Change0%
Ins Owners0.17%
Ins Owner Change0.1%
Market Cap500.17M
Analysts42.5
Price Target12.24 (-30.77%)
Short Float %2.2%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield 1.73%
Yearly Dividend0.32
Dividend Growth(5Y)-19.61%
DP7.77%
Div Incr Years0
Div Non Decr Years3
Ex-Date06-09 2025-06-09 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.71%
Min EPS beat(2)-10.82%
Max EPS beat(2)32.23%
EPS beat(4)3
Avg EPS beat(4)65.84%
Min EPS beat(4)-10.82%
Max EPS beat(4)142.33%
EPS beat(8)4
Avg EPS beat(8)-584.21%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-40%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.46%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.31
Fwd PE 4.81
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB 0.74
EV/EBITDA 3.42
EPS(TTM)4.1
EY23.19%
EPS(NY)3.68
Fwd EY20.79%
FCF(TTM)-3.59
FCFYN/A
OCF(TTM)-2.23
OCFYN/A
SpS74.68
BVpS37.56
TBVpS24.04
PEG (NY)4.76
PEG (5Y)0.31
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 11.02%
ROCE 8.82%
ROIC 5.83%
ROICexc 6.39%
ROICexgc 7.87%
OM 9.31%
PM (TTM) 5.54%
GM 21.9%
FCFM N/A
ROA(3y)2.2%
ROA(5y)2.55%
ROE(3y)6.18%
ROE(5y)8.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-13.32%
ROICexcg growth 5Y5.94%
ROICexc growth 3Y-13.52%
ROICexc growth 5Y5.5%
OM growth 3Y-11.53%
OM growth 5Y1.8%
PM growth 3Y-2.52%
PM growth 5Y14.63%
GM growth 3Y-7.09%
GM growth 5Y-2.42%
F-Score5
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA 1.98
Cap/Depr 55.6%
Cap/Sales 1.83%
Interest Coverage 3.44
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 1.29
Altman-Z 1.86
F-Score5
WACC8.66%
ROIC/WACC0.67
Cap/Depr(3y)83.84%
Cap/Depr(5y)91.05%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)888.46%
EPS 3Y-5.31%
EPS 5Y14.04%
EPS Q2Q%318.52%
EPS Next Y0.91%
EPS Next 2Y6.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.82%
Revenue growth 3Y-2.86%
Revenue growth 5Y2.1%
Sales Q2Q%1.51%
Revenue Next Year11.92%
Revenue Next 2Y9.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y98200%
EBIT growth 3Y-14.06%
EBIT growth 5Y3.94%
EBIT Next Year57.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.87%
FCF growth 3Y-67.81%
FCF growth 5Y-35.4%
OCF growth 1Y8.83%
OCF growth 3Y-54.22%
OCF growth 5Y-24.28%